Marshall Wace, LLP Rezolute, Inc. Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Rezolute, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,845,247 shares of RZLT stock, worth $9.15 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,845,247
Previous 843,144
118.85%
Holding current value
$9.15 Million
Previous $4.02 Million
33.08%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding RZLT
# of Institutions
82Shares Held
39.7MCall Options Held
402KPut Options Held
19.4K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$55.9 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$11.8 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.11MShares$10.5 Million1.66% of portfolio
-
Blackstone Inc New York, NY1.74MShares$8.65 Million0.02% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.7MShares$8.43 Million0.55% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $193M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...